US Stock MarketDetailed Quotes

LSTA Lisata Therapeutics

Watchlist
  • 2.853
  • +0.123+4.51%
Close May 1 16:00 ET
23.70MMarket Cap-1105P/E (TTM)

Lisata Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
5.38%-20.03M
37.09%-4.07M
10.38%-3.58M
17.34%-4.18M
-45.27%-8.2M
4.83%-21.17M
-40.49%-6.47M
20.66%-4M
-9.40%-5.06M
29.25%-5.64M
Net income from continuing operations
61.57%-20.84M
10.43%-5.37M
85.93%-5.26M
39.22%-4.03M
-46.40%-6.19M
-97.43%-54.23M
11.83%-5.99M
-439.67%-37.38M
-16.61%-6.63M
47.59%-4.23M
Operating gains losses
--3K
--0
--0
--0
--3K
----
----
----
----
----
Depreciation and amortization
173.91%189K
0.00%47K
487.50%47K
571.43%47K
585.71%48K
25.45%69K
487.50%47K
-42.86%8K
-58.82%7K
-56.25%7K
Other non cash items
----
----
----
----
----
--30.39M
--0
----
----
----
Change In working capital
44.40%-462K
215.65%1.03M
-17.63%1.61M
-165.67%-528K
4.82%-2.57M
-228.44%-831K
-172.37%-888K
529.35%1.95M
2,014.29%804K
-218.16%-2.7M
-Change in prepaid assets
2.49%-824K
41.65%-510K
9.57%847K
118.22%491K
-70.49%-1.65M
-86.53%-845K
-217.16%-874K
2,242.42%773K
-57.63%225K
45.04%-969K
-Change in payables and accrued expense
139.46%88K
2,008.22%1.39M
-33.18%747K
-287.07%-969K
39.36%-1.08M
-117.84%-223K
-108.27%-73K
485.34%1.12M
178.72%518K
-314.15%-1.79M
-Change in other current assets
15.61%274K
144.07%144K
-78.33%13K
-181.97%-50K
192.98%167K
258.00%237K
114.68%59K
-30.23%60K
-28.24%61K
-29.63%57K
Cash from discontinued investing activities
Operating cash flow
5.38%-20.03M
37.09%-4.07M
10.38%-3.58M
17.34%-4.18M
-45.27%-8.2M
4.83%-21.17M
-40.49%-6.47M
20.66%-4M
-9.40%-5.06M
29.25%-5.64M
Investing cash flow
Cash flow from continuing investing activities
-65.06%10.1M
-180.41%-5.71M
441.88%12.25M
-102.83%-725K
170.43%4.29M
152.67%28.91M
-56.82%7.11M
-54.23%2.26M
328.79%25.63M
90.64%-6.09M
Net PPE purchase and sale
--0
--0
--0
----
----
-375.00%-285K
---26K
---24K
----
----
Net investment purchase and sale
-68.93%10.1M
-180.12%-5.71M
378.77%12.25M
-102.02%-725K
170.43%4.29M
159.30%32.52M
-56.67%7.13M
-188.97%-4.4M
421.87%35.87M
90.64%-6.09M
Net other investing changes
----
----
----
----
----
---3.32M
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
-65.06%10.1M
-180.41%-5.71M
441.88%12.25M
-102.83%-725K
170.43%4.29M
152.67%28.91M
-56.82%7.11M
-54.23%2.26M
328.79%25.63M
90.64%-6.09M
Financing cash flow
Cash flow from continuing financing activities
271.88%385K
71.43%24K
93.94%-6K
1,458.62%452K
49.40%-85K
-100.26%-224K
-33.33%14K
-54.69%-99K
31.82%29K
-100.20%-168K
Net common stock issuance
646.51%321K
71.43%24K
--0
----
----
-99.95%43K
-33.33%14K
--0
----
----
Proceeds from stock option exercised by employees
--155K
--0
--0
----
----
--0
--0
--0
----
----
Net other financing activities
65.92%-91K
--0
93.94%-6K
--0
49.40%-85K
-7.66%-267K
--0
-54.69%-99K
--0
8.70%-168K
Cash from discontinued financing activities
Financing cash flow
271.88%385K
71.43%24K
93.94%-6K
1,458.62%452K
49.40%-85K
-100.26%-224K
-33.33%14K
-54.69%-99K
31.82%29K
-100.20%-168K
Net cash flow
Beginning cash position
30.46%32.15M
3.02%32.43M
-28.96%23.69M
120.88%28.16M
30.46%32.15M
49.27%24.65M
146.46%31.48M
157.81%33.35M
-55.65%12.75M
49.27%24.65M
Current changes in cash
-226.98%-9.55M
-1,596.78%-9.76M
571.84%8.66M
-121.63%-4.46M
66.45%-3.99M
-7.60%7.52M
-94.51%652K
-1,026.38%-1.84M
230.31%20.6M
-197.29%-11.9M
Effect of exchange rate changes
-60.00%-16K
-416.67%-76K
320.59%75K
---8K
---7K
---10K
--24K
---34K
--0
--0
End cash Position
-29.74%22.59M
-29.74%22.59M
3.02%32.43M
-28.96%23.69M
120.88%28.16M
30.46%32.15M
30.46%32.15M
146.46%31.48M
157.81%33.35M
-55.65%12.75M
Free cash flow
6.63%-20.03M
37.34%-4.07M
10.91%-3.58M
21.01%-4.18M
-45.27%-8.2M
3.81%-21.46M
-41.05%-6.49M
20.18%-4.02M
-13.01%-5.3M
29.25%-5.64M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 5.38%-20.03M37.09%-4.07M10.38%-3.58M17.34%-4.18M-45.27%-8.2M4.83%-21.17M-40.49%-6.47M20.66%-4M-9.40%-5.06M29.25%-5.64M
Net income from continuing operations 61.57%-20.84M10.43%-5.37M85.93%-5.26M39.22%-4.03M-46.40%-6.19M-97.43%-54.23M11.83%-5.99M-439.67%-37.38M-16.61%-6.63M47.59%-4.23M
Operating gains losses --3K--0--0--0--3K--------------------
Depreciation and amortization 173.91%189K0.00%47K487.50%47K571.43%47K585.71%48K25.45%69K487.50%47K-42.86%8K-58.82%7K-56.25%7K
Other non cash items ----------------------30.39M--0------------
Change In working capital 44.40%-462K215.65%1.03M-17.63%1.61M-165.67%-528K4.82%-2.57M-228.44%-831K-172.37%-888K529.35%1.95M2,014.29%804K-218.16%-2.7M
-Change in prepaid assets 2.49%-824K41.65%-510K9.57%847K118.22%491K-70.49%-1.65M-86.53%-845K-217.16%-874K2,242.42%773K-57.63%225K45.04%-969K
-Change in payables and accrued expense 139.46%88K2,008.22%1.39M-33.18%747K-287.07%-969K39.36%-1.08M-117.84%-223K-108.27%-73K485.34%1.12M178.72%518K-314.15%-1.79M
-Change in other current assets 15.61%274K144.07%144K-78.33%13K-181.97%-50K192.98%167K258.00%237K114.68%59K-30.23%60K-28.24%61K-29.63%57K
Cash from discontinued investing activities
Operating cash flow 5.38%-20.03M37.09%-4.07M10.38%-3.58M17.34%-4.18M-45.27%-8.2M4.83%-21.17M-40.49%-6.47M20.66%-4M-9.40%-5.06M29.25%-5.64M
Investing cash flow
Cash flow from continuing investing activities -65.06%10.1M-180.41%-5.71M441.88%12.25M-102.83%-725K170.43%4.29M152.67%28.91M-56.82%7.11M-54.23%2.26M328.79%25.63M90.64%-6.09M
Net PPE purchase and sale --0--0--0---------375.00%-285K---26K---24K--------
Net investment purchase and sale -68.93%10.1M-180.12%-5.71M378.77%12.25M-102.02%-725K170.43%4.29M159.30%32.52M-56.67%7.13M-188.97%-4.4M421.87%35.87M90.64%-6.09M
Net other investing changes -----------------------3.32M--0------------
Cash from discontinued investing activities
Investing cash flow -65.06%10.1M-180.41%-5.71M441.88%12.25M-102.83%-725K170.43%4.29M152.67%28.91M-56.82%7.11M-54.23%2.26M328.79%25.63M90.64%-6.09M
Financing cash flow
Cash flow from continuing financing activities 271.88%385K71.43%24K93.94%-6K1,458.62%452K49.40%-85K-100.26%-224K-33.33%14K-54.69%-99K31.82%29K-100.20%-168K
Net common stock issuance 646.51%321K71.43%24K--0---------99.95%43K-33.33%14K--0--------
Proceeds from stock option exercised by employees --155K--0--0----------0--0--0--------
Net other financing activities 65.92%-91K--093.94%-6K--049.40%-85K-7.66%-267K--0-54.69%-99K--08.70%-168K
Cash from discontinued financing activities
Financing cash flow 271.88%385K71.43%24K93.94%-6K1,458.62%452K49.40%-85K-100.26%-224K-33.33%14K-54.69%-99K31.82%29K-100.20%-168K
Net cash flow
Beginning cash position 30.46%32.15M3.02%32.43M-28.96%23.69M120.88%28.16M30.46%32.15M49.27%24.65M146.46%31.48M157.81%33.35M-55.65%12.75M49.27%24.65M
Current changes in cash -226.98%-9.55M-1,596.78%-9.76M571.84%8.66M-121.63%-4.46M66.45%-3.99M-7.60%7.52M-94.51%652K-1,026.38%-1.84M230.31%20.6M-197.29%-11.9M
Effect of exchange rate changes -60.00%-16K-416.67%-76K320.59%75K---8K---7K---10K--24K---34K--0--0
End cash Position -29.74%22.59M-29.74%22.59M3.02%32.43M-28.96%23.69M120.88%28.16M30.46%32.15M30.46%32.15M146.46%31.48M157.81%33.35M-55.65%12.75M
Free cash flow 6.63%-20.03M37.34%-4.07M10.91%-3.58M21.01%-4.18M-45.27%-8.2M3.81%-21.46M-41.05%-6.49M20.18%-4.02M-13.01%-5.3M29.25%-5.64M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg